Christoph Stippich
Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.
Polymeris A, Karwacki G, Siepen B, Schaedelin S, Tsakiris D, Stippich C, Guzman R, Nickel C, Sprigg N, Kägi G, Vehoff J, Barinka F, Thilemann S, Maurer M, Wagner B, Traenka C, Gensicke H, De Marchis G, Bonati L, Fischer U, Z'Graggen W, Nedeltchev K, Wegener S, Baumgartner P, Engelter S, Seiffge D, Peters N, Lyrer P, TICH-NOAC Investigators. Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial. Stroke 2023; 54:2223-2234.
Jul 19, 2023Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.
Jul 19, 2023Stroke 2023; 54:2223-2234
Polymeris Alexandros A, Karwacki Grzegorz M, Siepen Bernhard M, Schaedelin Sabine A, Tsakiris Dimitrios A, Stippich Christoph, Guzman Raphael, Nickel Christian H, Sprigg Nikola, Kägi Georg, Vehoff Jochen, Barinka Filip, Thilemann Sebastian, Maurer Marina, Wagner Benjamin, Traenka Christopher, Gensicke Henrik, De Marchis Gian Marco, Bonati Leo H, Fischer Urs, Z'Graggen Werner J, Nedeltchev Krassen, Wegener Susanne, Baumgartner Philipp, Engelter Stefan T, Seiffge David Julian, Peters Nils, Lyrer Philippe A, TICH-NOAC Investigators
Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
Engelter S, Traenka C, Gensicke H, Schaedelin S, Luft A, Simonetti B, Fischer U, Michel P, Sirimarco G, Kägi G, Vehoff J, Nedeltchev K, Kahles T, Kellert L, Rosenbaum S, von Rennenberg R, Sztajzel R, Leib S, Jung S, Gralla J, Bruni N, Seiffge D, Feil K, Polymeris A, Steiner L, Hamann J, Bonati L, Brehm A, De Marchis G, Peters N, Stippich C, Nolte C, Christensen H, Wegener S, Psychogios M, Arnold M, Lyrer P, TREAT-CAD investigators. Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial. Lancet Neurol 2021; 20:341-350.
Mar 23, 2021Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
Mar 23, 2021Lancet Neurol 2021; 20:341-350
Engelter Stefan T, Traenka Christopher, Gensicke Henrik, Schaedelin Sabine A, Luft Andreas R, Simonetti Barbara Goeggel, Fischer Urs, Michel Patrik, Sirimarco Gaia, Kägi Georg, Vehoff Jochen, Nedeltchev Krassen, Kahles Timo, Kellert Lars, Rosenbaum Sverre, von Rennenberg Regina, Sztajzel Roman F, Leib Stephen L, Jung Simon, Gralla Jan, Bruni Nicole, Seiffge David Julian, Feil Katharina, Polymeris Alexandros A, Steiner Levke, Hamann Janne, Bonati Leo H, Brehm Alex, De Marchis Gian Marco, Peters Nils, Stippich Christoph, Nolte Christian H, Christensen Hanne, Wegener Susanne, Psychogios Marios-Nikos, Arnold Marcel, Lyrer Philippe A, TREAT-CAD investigators
Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial
Traenka C, Engelter S, Lyrer P, Psychogios M, Stippich C, Brehm A, Sztaizel R, Rosenbaum S, Kellert L, Nolte C, Kahles T, Kägi G, Michel P, Arnold M, Luft A, Schaedelin S, Gensicke H, TREAT-CAD investigators. Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial. Eur Stroke J 2020; 5:309-319.
Jun 29, 2020Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial
Jun 29, 2020Eur Stroke J 2020; 5:309-319
Traenka Christopher, Engelter Stefan T, Lyrer Philippe, Psychogios Marios, Stippich Christoph, Brehm Alex, Sztaizel Roman, Rosenbaum Sverre, Kellert Lars, Nolte Christian H, Kahles Timo, Kägi Georg, Michel Patrik, Arnold Marcel, Luft Andreas, Schaedelin Sabine, Gensicke Henrik, TREAT-CAD investigators
Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation
Conen D, Sticherling C, Bonati L, Ehret G, Moutzouri E, Fischer U, Monsch A, Stippich C, Wuerfel J, Sinnecker T, Coslovsky M, Schwenkglenks M, Kühne M, Osswald S, Meyre P, Blum S, Rodondi N, Müller A, Beer J, Ammann P, Moschovitis G, Auricchio A, Hayoz D, Kobza R, Shah D, Novak J, Schläpfer J, Di Valentino M, Aeschbacher S, Swiss-AF Study Investigators. Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation. J Am Coll Cardiol 2019; 73:989-999.
Mar 12, 2019Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation
Mar 12, 2019J Am Coll Cardiol 2019; 73:989-999
Conen David, Sticherling Christian, Bonati Leo H, Ehret Georg, Moutzouri Elisavet, Fischer Urs, Monsch Andreas U, Stippich Christoph, Wuerfel Jens, Sinnecker Tim, Coslovsky Michael, Schwenkglenks Matthias, Kühne Michael, Osswald Stefan, Meyre Pascal, Blum Steffen, Rodondi Nicolas, Müller Andreas, Beer Juerg H, Ammann Peter, Moschovitis Giorgio, Auricchio Angelo, Hayoz Daniel, Kobza Richard, Shah Dipen, Novak Jan, Schläpfer Jürg, Di Valentino Marcello, Aeschbacher Stefanie, Swiss-AF Study Investigators
Characterizing ipsilateral thalamic diaschisis in symptomatic cerebrovascular steno-occlusive patients.
Hendrik Bas van Niftrik C, Sebök M, Muscas G, Piccirelli M, Serra C, Krayenbühl N, Pangalu A, Bozinov O, Luft A, Stippich C, Regli L, Fierstra J. Characterizing ipsilateral thalamic diaschisis in symptomatic cerebrovascular steno-occlusive patients. J Cereb Blood Flow Metab 2019; 40:563-573.
Feb 12, 2019Characterizing ipsilateral thalamic diaschisis in symptomatic cerebrovascular steno-occlusive patients.
Feb 12, 2019J Cereb Blood Flow Metab 2019; 40:563-573
Hendrik Bas van Niftrik Christiaan, Sebök Martina, Muscas Giovanni, Piccirelli Marco, Serra Carlo, Krayenbühl Niklaus, Pangalu Athina, Bozinov Oliver, Luft Andreas, Stippich Christoph, Regli Luca, Fierstra Jorn
Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke – Results from the SWISS registry
Traenka C, Steiner L, Kägi G, Luft A, Sztajzel R, Fischer U, Bonati L, Peters N, Michel P, Lyrer P, Arnold M, Wegener S, Weber J, Vehoff J, Jung S, Gralla J, Kurmann R, Stippich C, Goeggel Simonetti B, Gensicke H, Mueller H, Lovblad K, Eskandari A, Puccinelli F, Engelter S. Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke – Results from the SWISS registry. European Stroke Journal 2018; 3:47-56.
Jan 3, 2018Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke – Results from the SWISS registry
Jan 3, 2018European Stroke Journal 2018; 3:47-56
Traenka Christopher, Steiner Levke, Kägi Georg, Luft Andreas, Sztajzel Roman, Fischer Urs, Bonati Leo H, Peters Nils, Michel Patrik, Lyrer Philippe A, Arnold Marcel, Wegener Susanne, Weber Johannes, Vehoff Jochen, Jung Simon, Gralla Jan, Kurmann Rebekka, Stippich Christoph, Goeggel Simonetti Barbara, Gensicke Henrik, Mueller Hubertus, Lovblad Karl-Olof, Eskandari Ashraf, Puccinelli Francesco, Engelter Stefan T
Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.
Seiffge D, Traenka C, Polymeris A, Thilemann S, Wagner B, Hert L, Delignette-Muller M, Gensicke H, Peters N, Nickel C, Stippich C, Sutter R, Marsch S, Fisch U, Guzman R, De Marchis G, Lyrer P, Bonati L, Tsakiris D, Engelter S. Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice. J Stroke 2017; 19:347-355.
Sep 6, 2017Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.
Sep 6, 2017J Stroke 2017; 19:347-355
Seiffge David Julian, Traenka Christopher, Polymeris Alexandros A, Thilemann Sebastian, Wagner Benjamin, Hert Lisa, Delignette-Muller Marie Laure, Gensicke Henrik, Peters Nils, Nickel Christian H, Stippich Christoph, Sutter Raoul, Marsch Stephan C, Fisch Urs, Guzman Raphael, De Marchis Gian Marco, Lyrer Philippe A, Bonati Leo H, Tsakiris Dimitrios A, Engelter Stefan T
Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation
Conen D, Sticherling C, Bonati L, Ehret G, Roten L, Fischer U, Monsch A, Stippich C, Wuerfel J, Schwenkglenks M, Kuehne M, Erne P, Di Valentino M, Novak J, Rodondi N, Mueller A, Beer J, Auricchio A, Ammann P, Hayoz D, Kobza R, Moschovitis G, Shah D, Schlaepfer J, Osswald S. Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation. Swiss Med Wkly 2017; 147:w14467.
Jul 11, 2017Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation
Jul 11, 2017Swiss Med Wkly 2017; 147:w14467
Conen David, Sticherling Christian, Bonati Leo, Ehret Georg, Roten Laurent, Fischer Urs, Monsch Andreas, Stippich Christoph, Wuerfel Jens, Schwenkglenks Matthias, Kuehne Michael, Erne Paul, Di Valentino Marcello, Novak Jan, Rodondi Nicolas, Mueller Andreas, Beer Juerg, Auricchio Angelo, Ammann Peter, Hayoz Daniel, Kobza Richard, Moschovitis Giorgio, Shah Dipen, Schlaepfer Juerg, Osswald Stefan
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Giulio D, Kamm C, Mattle H, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P, Yaldizli O, Gobbi C, Kappos L, Kuhle J, Louvion J, Derfuss T, Stippich C, Benkert P, Lorscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E, Sprenger T, SMSC Scientific Board. The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PloS one 2016; 11:e0152347.
Mar 31, 2016The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Mar 31, 2016PloS one 2016; 11:e0152347
Giulio Disanto, Kamm Christian P, Mattle Heinrich P, Lotter Christoph, Du Pasquier Renaud, Schluep Myriam, Pot Caroline, Lalive Patrice H, Yaldizli Ozgür, Gobbi Claudio, Kappos Ludwig, Kuhle Jens, Louvion Jean-François, Derfuss Tobias, Stippich Christoph, Benkert Pascal, Lorscheider Johannes, Müller Stefanie, Vehoff Jochen, Zecca Chiara, Ramseier Simon, Achtnichts Lutz, Findling Oliver, Nedeltchev Krassen, Radue Ernst-Wilhelm, Sprenger Till, SMSC Scientific Board